Isoniazid associated psychosis: case series from a tertiary care centre

Isoniazid associated psychosis: case series from a tertiary care centre

Isoniazid (INH) is a commonly used first line antitubercular drug. INH associated psychosis is a rare psychiatric manifestation. We report two cases of pulmonary tuberculosis, where the patients developed psychosis after being given a therapeutic dose of INH. In vulnerable patients, INH may cause ch...

Full description

Bibliographic Details
Main Authors:	Hemendra Singh, Gayathri Devi HJ, Mamatha Chabaria, Kartik Shekar
Format:	Article
Language:	English
Published:	Academy Publisher 2018-07-01
Series:	Open Journal of Psychiatry and Allied Sciences
Subjects:	Antitubercular Agents Antipsychotic Agents Pyridoxine
Online Access:	https://www.ojpas.com/get_file.php?id=32408329&vnr=348665

Similar Items

Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents
by: Edoardo Spina, et al.
Published: (2020-12-01)

Secreting Male Breast: A Clinical Oddity
by: Prashant Badole, et al.
Published: (2024-11-01)

Pengubatan moden untuk penyakit tuberkulosis /
by: 179730 Horne, N. W., et al.
Published: ([19-)

Sputum Smear Non-conversion at the End of Intensive Phase of Tuberculosis Treatment at a Tertiary Center: A Descriptive Cross-sectional study
by: Naveen Prakash Shah, et al.
Published: (2021-11-01)

Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021-07-01)

Isoniazid-induced alopecia
by: K B Gupta, et al.
Published: (2011-01-01)

Tuberculosis : laboratory diagnosis and treatment strategies /
by: McHugh, Timothy D. (Timothy Daniel)
Published: (c201)

Clinical research progress of tuberculous meningitis
by: Zhan-yun MA, et al.
Published: (2014-08-01)

Acute Isoniazid Neurotoxicity
by: J Gordon Millichap
Published: (1995-06-01)

Improvement in Outcomes with a New Bedaquiline-based Regimen in Postoperative Cases of Drug-resistant Tuberculosis of the Spine: A Case Series
by: Soutrik Kundu, et al.
Published: (2024-01-01)

Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis
by: Yi-Ting Lin, et al.
Published: (2015-02-01)

Isoniazid-induced thrombocytopenia in a patient with ocular tuberculosis
by: Preeti Gupta, et al.
Published: (2019-01-01)

Tuberculous meningitis: neuroimaging features, clinical staging and outcome
by: Al-Edrus, Sharifah Aishah, et al.
Published: (2007)

Development of nanodelivery systems for anti-tuberculosis drugs using metal hydroxides nanolayered hosts
by: Saifullah
Published: (2014)

Real World Experience of Bedaquiline-Based Anti-Tubercular Regime in Multi-Drug Resistant Tuberculosis.
by: Vikas Marwah, et al.
Published: (2025-01-01)

Paradoxical Deterioration During Anti-Tuberculous Therapy in Non-HIV-Infected Patients with Pleural Tuberculosis: A Pragmatic Approach
by: Luis Corral-Gudino, et al.
Published: (2016-09-01)

Primary nasal tuberculosis: A case report
by: Stojanović Jasmina, et al.
Published: (2013-01-01)

Is the Pharmacokinetics of First-Line Anti-TB Drugs a Cause of High Mortality Rates in TB Patients Admitted to the ICU? A Non-Compartmental Pharmacokinetic Analysis
by: Francisco Beraldi-Magalhaes, et al.
Published: (2023-06-01)

A rare association of tonsillar tuberculosis and lichen scrofulosorum
by: Anshika Harit, et al.
Published: (2021-02-01)

A hybrid model for predicting response to risperidone after first-episode psychosis
by: Giovany Oliveira Costa, et al.
Published: (2025-03-01)

Myocarditis in patients on long-term antipsychotics –mechanism, management and recent updates
by: Patterson Daniel, et al.
Published: (2023-03-01)

A Case of Seizure and Metabolic Acidosis Due to Renal Adjustment Dosage of Isoniazid in an Elderly Woman
by: Young Shin Shin, et al.
Published: (2014-06-01)

Catechin ameliorates hepatocellular damage caused by coadministration of isoniazid and rifampicin
by: Sonam Sahu, et al.
Published: (2024-08-01)

An Atypical Sellar Mass: Sellar Tuberculoma in a Young Patient - Case Report
by: Arwa Moiz Jamali, et al.
Published: (2023-12-01)

Synthesis and Analytical Characterization of Cyclization Products of 3-Propargyloxy-5-benzyloxy-benzoic Acid Methyl Ester
by: Matteo Mori, et al.
Published: (2024-04-01)

Incidence, Diagnosis and Treatment of Otorhinolaryngological, Head and Neck Tuberculosis: A Prospective Clinical Study
by: Biban Chhabra, et al.
Published: (2023-10-01)

The Trend of Tuberculosis in Tekirdağ
by: Hayati Güneş, et al.
Published: (2015-04-01)

Assessment of factors associated with potential drug-drug interactions in patients with tuberculosis and HIV/AIDS
by: Natália Helena de Resende, et al.
Published: (2021-07-01)

Formulation of dispersible isoniazid/pyridoxine fixed-dose combination tablets for isoniazid preventive therapy in pediatrics
by: M. W. Mwangi, et al.
Published: (2020-01-01)

Quetiapine-induced Priapism Requiring Frequent Emergency Admissions: A Case Report
by: Jon C. Jackson, et al.
Published: (2015-01-01)

Different types of akathisia: clinical analysis on three cases
by: Lei WANG, et al.
Published: (2018-09-01)

Onset of Action of Selected Second-Generation Antipsychotics (Pines)–A Systematic Review and Meta-Analyses
by: Rikke Meyer, et al.
Published: (2022-12-01)

A Prospective Study of Adverse Drug Reactions in Patients with Bipolar Disorder in Psychiatry Outpatient Department of a Tertiary Care Hospital
by: Aashal Shah, et al.
Published: (2017-05-01)

Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients
by: Franciska de Beer, et al.
Published: (2024-10-01)

Recent advancements in tuberculosis (TB) treatment regimens
by: Shyamala Ravikoti, et al.
Published: (2025-02-01)

Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review
by: Denise Rossato Silva, et al.
Published: (2025-01-01)

Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis
by: Nicole F. Maranchick, et al.
Published: (2022-12-01)

Multidrug-resistant Tuberculosis Management in Resource-limited Settings
by: Eva Nathanson, et al.
Published: (2006-09-01)

Six-Month Response to Delamanid Treatment in MDR TB Patients
by: Cathy Hewison, et al.
Published: (2017-10-01)

TOXICOLOGICAL ESTIMATION OF COMBINED ANTITUBERCULAR PREPARATION «PROTUB-2®»
by: K. I. Usov, et al.
Published: (2012-07-01)